April 22, 2024

bio:cap europe 2026

bio:cap europe 2026

bio:cap europe

bio:cap is Europe’s Life Science & AI Investival with one clear mission:
connecting breakthrough science to the funding that turns ideas into impact.

We unite global investors, founders, and industry leaders to spotlight and back the most promising innovations emerging from European research. bio:cap transforms cutting-edge science into investable ventures and fast-tracks their journey from lab bench to market front.

Our goal?
to benefit patients and society and to help create a resilient and sustainable European bioeconomy.

What is an Investival?

An Investival combines the best of both worlds: investment and festival.

bio:cap blends the depth of a traditional investor conference with the energy, openness, and creativity of a festival. Expect inspiring keynotes, curated matchmaking, and deep-dive sessions by day – followed by relaxed networking and standout social events in the evening. bio:cap is more than just a conference – it’s where deals, ideas, and visions come to life in a whole new atmosphere.

09 – 11 June 2026
CityCube, Messe Berlin


BioRN members receive a 60 % discount for the first 100 Tickets and 10% discount on booth bookings (valid until March 31, 2026)

Please contact Nicole Hecht (nh(at)biorn.org) for the Discount Code and more Information.

register now

Our latest News

discover more
RHEACELL makes second location in Heidelberg visible

RHEACELL makes second location in Heidelberg visible

Heidelberg, January 28, 2026 – RHEACELL GmbH & Co. KG is continuing to expand its presence in Heidelberg and moved into a second location in the Pfaffengrund district in August last year. At the start of the year, the location is now also becoming visible to the outside world: this week, the company logo will […]

TUM Researchers receive two ERC Grants

TUM Researchers receive two ERC Grants

The European Research Council’s (ERC) Proof of Concept Grants are designed to help researchers turn their findings into real‑world innovations. Two ERC‑funded follow‑up projects at TUM will each receive approximately 150,000 euros in support. The projects focus on virus‑driven cancer treatments and new ways to supply electrons for enzyme‑based technologies. Researchers at TUM have secured […]

Weight Loss in Cancer: Organs Respond to the Disease in a Coordinated Way

Weight Loss in Cancer: Organs Respond to the Disease in a Coordinated Way

Cachexia is a metabolic disorder that causes uncontrolled weight loss and muscle wasting in chronic diseases and cancer. A new study by Helmholtz Munich, in collaboration with the Institute of Physiology of the Czech Academy of Sciences in Prague, Heidelberg University Hospital, the German Center for Diabetes Research (DZD), and the German Center for Cardiovascular […]

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp